18F-FB-T84.66

N/A

Report date: 2025/11/12 17:54:38

Base Information

Drug Name18F-FB-T84.66

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionAnti-CEACAM5

TargetsCarcinoembryonic antigen related cell adhesion molecule 5

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesStanford University School of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesStanford University School of Medicine

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A